Coperion Delivers Two of the Biggest Polyoxymethylene (POM) Compounding Lines to China

Coperion Werner & Pfleiderer GmbH & Co. KG, Stuttgart/Germany, has delivered its two so far biggest compounding lines for polyoxymethylene (POM) to a company in the eastern part of China.

Having been put into service in May of this year, the compounding lines are used for the compounding, degassing, stabilizing and pelletizing of the raw POM polymer. Each compounding system is rated for an output of 4,000 kg/hour and comprises the material feed system, a ZSK MEGAcompounder with a 250 mm diameter screw, a continuous screen changer, a WRG 320 water-cooled die face pelletizer for 2 mm pellets, specially optimized for this application, and an intermediate silo for the dry end product.

Installed upstream of each MEGAcompounder is a gravimetric feed system with several feeders. During the compounding of the raw POM polymer there is a strong demand for degassing. In addition to the high degassing capacity due to the vacuum domes, the high torque of the ZSK MEGAcompounder has been found to best enhance the product quality.

For more information on polymer, click here.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Coperion GmbH. (2019, February 10). Coperion Delivers Two of the Biggest Polyoxymethylene (POM) Compounding Lines to China. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=13325.

  • MLA

    Coperion GmbH. "Coperion Delivers Two of the Biggest Polyoxymethylene (POM) Compounding Lines to China". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=13325>.

  • Chicago

    Coperion GmbH. "Coperion Delivers Two of the Biggest Polyoxymethylene (POM) Compounding Lines to China". AZoM. https://www.azom.com/news.aspx?newsID=13325. (accessed November 21, 2024).

  • Harvard

    Coperion GmbH. 2019. Coperion Delivers Two of the Biggest Polyoxymethylene (POM) Compounding Lines to China. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=13325.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.